Last reviewed · How we verify
NCT04163926
Optometric Follow-up After Cataract Surgery
NA trial testing Intervention Group cataract follow up in Cataract. Withdrawn.
30 August 2022
Quick facts
| Lead sponsor | Queen's University, Belfast |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Start date | 28 February 2022 |
| Primary completion | 30 August 2022 |
| Estimated completion | 28 September 2022 |
Drugs / interventions tested
- Intervention Group cataract follow up
- Usual Care consultant follow up
Conditions studied
- Cataract — all drugs for Cataract →
- Age-related Cataract — all drugs for Age-related Cataract →
Sponsor
Queen's University, Belfast
Who can join
50 and older, any sex, with Cataract or Age-related Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will investigate the effectiveness of an optometric follow up of cataract surgery versus an ophthalmic surgeon follow up. It will investigate patient satisfaction,safety and cost.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04163926
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Queen's University, Belfast trials
Trials by the same sponsor.
- NCT07373041 — Heart Failure Carer Support Programme: Implementation Testing in the UK. · NA · not yet recruiting
- NCT07482839 — Feasibility Study of a Compassionate Mindful Resilience (CMR) Intervention to Improve Mental Health Well-being Outcomes · NA · not yet recruiting
- NCT07333924 — Randomised Study Within a Review (SWAR) to Compare Communication of the Findings of Systematic Reviews to the Public by · Phase 3 · completed
- NCT06896799 — Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM) · NA · recruiting
- NCT06749327 — Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04163926 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen's University, Belfast
- Last refreshed: 15 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04163926.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing